KR890007728A - Painkiller - Google Patents

Painkiller Download PDF

Info

Publication number
KR890007728A
KR890007728A KR870012244A KR870012244A KR890007728A KR 890007728 A KR890007728 A KR 890007728A KR 870012244 A KR870012244 A KR 870012244A KR 870012244 A KR870012244 A KR 870012244A KR 890007728 A KR890007728 A KR 890007728A
Authority
KR
South Korea
Prior art keywords
pharmaceutical preparation
preparation according
tizanidine
ibuprofen
patient
Prior art date
Application number
KR870012244A
Other languages
Korean (ko)
Inventor
라르디 페터
Original Assignee
예안 크라메트, 한스 루돌프하우스
산도즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 예안 크라메트, 한스 루돌프하우스, 산도즈 리미티드 filed Critical 예안 크라메트, 한스 루돌프하우스
Publication of KR890007728A publication Critical patent/KR890007728A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Abstract

내용 없음No content

Description

진통제 제조방법Painkiller

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (14)

티자니딘 또는 이들의 약학적 허용염과 이부프로펜 또는 이들의 약학적 허용염을 함유하는 약학제제.A pharmaceutical formulation containing tizanidine or a pharmaceutically acceptable salt thereof and ibuprofen or a pharmaceutically acceptable salt thereof. 제1항에 있어서, 단위 투약형태인것을 특징으로하는 약학제제.The pharmaceutical preparation according to claim 1, which is in unit dosage form. 제1항에 있어서, 경구투여용 단위투약형태인 것을 특징으로 하는 약학제제.The pharmaceutical preparation according to claim 1, which is in unit dosage form for oral administration. 제1항에 있어서, 정제형태인것을 특징으로 하는 약학제제.The pharmaceutical preparation according to claim 1, which is in the form of a tablet. 제1항에 있어서, 1mg의 티자니딘을 함유하는 것을 특징으로 하는 약학제제.The pharmaceutical preparation according to claim 1, which contains 1 mg of tizanidine. 제1항에 있어서, 2mg의 티자니딘을 함유하는 것을 특징으로 하는 약학제제.The pharmaceutical preparation according to claim 1, which contains 2 mg of tizanidine. 제1항에 있어서, 2내지 4mg의 티자니딘을 함유하는 것을 특징으로 하는 약학제제.The pharmaceutical preparation according to claim 1, which contains 2 to 4 mg of tizanidine. 제1항에 있어서, 이부프로펜에 대한 티자니딘의 중량비가 1:50내지 1:200인것을 특징으로 하는 약학제제.The pharmaceutical preparation according to claim 1, wherein the weight ratio of tizanidine to ibuprofen is 1:50 to 1: 200. 제1항에 있어서, 이부프로펜에 대한 티자니딘의 중량비가 1;100인것을 특징으로 약학제제.The pharmaceutical preparation according to claim 1, wherein the weight ratio of tizanidine to ibuprofen is 1; 100. 개량된 진통효과를 가지는 약학제제의 제조방법에 있어서, 티자니딘과 이부프로펜을 일정하게 혼합하고, 필요에 따라서 단위투약형태로 성형하는 것을 특징으로 하는 방법.A method for producing a pharmaceutical preparation having an improved analgesic effect, wherein tizanidine and ibuprofen are constantly mixed and molded into unit dosage forms as necessary. 진통을 요하는 환자에게 진통을 유발하는 방법에 있어서, 제1항내지 제9항중 한항에 의한 유효량의 약학제제를 상기 환자에게 투여하는 것을 특징으로 하는 방법.A method of inducing analgesia in a patient in need of pain, the method comprising administering to the patient an effective amount of the pharmaceutical preparation according to any one of claims 1 to 9. 통증이 있는 근육경직과 관련된 통증 및 염증상태의 치료방법에 있어서, 제1항내지 제9항중 한항에 의한 유효량의 약학제제를 상기 환자에게 투여하는 것을 특징으로 하는 방법.A method of treating pain and inflammatory conditions associated with painful muscle stiffness, the method comprising administering to the patient an effective amount of the pharmaceutical preparation according to any one of claims 1 to 9. 제1항내지 제9항중 어느한항에 의한 약학제제의 진통제로서의 사용방법.A method of using the pharmaceutical preparation as an analgesic according to any one of claims 1 to 9. 제1항내지 제9항중 어느한항에 의한 약학제제의 통증이 있는 근육경직과 관련된 통증 및 염증상태 치료제로서의 사용방법.Use of the pharmaceutical preparation according to any one of claims 1 to 9 as a therapeutic agent for pain and inflammatory states associated with painful muscle stiffness. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR870012244A 1986-11-03 1987-11-02 Painkiller KR890007728A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3637240.4 1986-11-03
DE3637240 1986-11-03

Publications (1)

Publication Number Publication Date
KR890007728A true KR890007728A (en) 1989-07-05

Family

ID=6312966

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870012244A KR890007728A (en) 1986-11-03 1987-11-02 Painkiller

Country Status (18)

Country Link
JP (1) JPS63132834A (en)
KR (1) KR890007728A (en)
AU (1) AU8057587A (en)
BE (1) BE1000265A3 (en)
DD (1) DD300508A5 (en)
DK (1) DK574187A (en)
FR (1) FR2605884B1 (en)
GB (1) GB2197198A (en)
GR (1) GR871678B (en)
HU (1) HUT47849A (en)
IL (1) IL84344A0 (en)
IT (1) IT8748554A0 (en)
LU (1) LU87033A1 (en)
NL (1) NL8702523A (en)
PH (1) PH23276A (en)
PT (1) PT86061B (en)
SE (1) SE8704240L (en)
ZA (1) ZA878257B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
MXPA05005038A (en) * 2002-11-12 2005-07-01 Teva Pharma Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or bucally.
TR200703092A1 (en) 2007-05-08 2008-12-22 SANOVEL �LA� SAN. VE TiC. A.�. Flurbiprofen and muscle relaxant combinations
AU2013252491A1 (en) * 2012-04-27 2014-11-06 Troy Laboratories Pty Ltd Combination meloxicam and xylazine therapy in animals
WO2016012398A1 (en) 2014-07-21 2016-01-28 Sanovel Ilac Sanayi Ve Ticaret A.S. Zaltoprofen and muscle relaxant combinations
EP3197434A1 (en) 2014-09-24 2017-08-02 Sanovel Ilac Sanayi ve Ticaret A.S. Loxoprofen and antispastic drug combinations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3012837A1 (en) * 1979-04-10 1980-10-30 Sandoz Ag ANALGETIC AND MYOTONOLYTIC PREPARATIONS
GB2135884B (en) * 1983-03-09 1986-09-17 Sandoz Ltd Analgesic preparations containing tizanidine and paracetamol
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method

Also Published As

Publication number Publication date
DK574187A (en) 1988-05-04
IT8748554A0 (en) 1987-10-30
DD300508A5 (en) 1992-06-17
FR2605884A1 (en) 1988-05-06
DK574187D0 (en) 1987-11-02
AU8057587A (en) 1988-05-05
GB2197198A (en) 1988-05-18
GB8725538D0 (en) 1987-12-02
LU87033A1 (en) 1988-05-03
HUT47849A (en) 1989-04-28
PT86061A (en) 1987-12-01
PT86061B (en) 1990-11-07
ZA878257B (en) 1989-06-28
IL84344A0 (en) 1988-04-29
GR871678B (en) 1988-03-03
JPS63132834A (en) 1988-06-04
SE8704240D0 (en) 1987-10-30
FR2605884B1 (en) 1989-05-05
SE8704240L (en) 1988-05-04
PH23276A (en) 1989-06-23
BE1000265A3 (en) 1988-09-27
NL8702523A (en) 1988-06-01

Similar Documents

Publication Publication Date Title
BR9815439A (en) Continuous analgesia obtained with buprenorphine
KR880002515A (en) Fast absorbing and acting sullindac or a mixture of sodium sullindak and base
BR0108379A (en) Controlled release compositions containing opioid agonist and antagonist, method for preparing a controlled release opioid analgesic formulation with increased analgesic potency and delivery system through the dermis for an opioid analgesic
ATE214289T1 (en) PERNASAL COMPOSITION AND PERNASAL PREPARATION CONTAINING SAME
KR920702216A (en) Use of Acetyl D-Carnitine in Glaucoma Treatment
KR890001533A (en) Pharmaceutical compositions containing levodopa methyl esters, their preparation and therapeutic applications
KR930007441A (en) medicine
RU98111594A (en) PHARMACEUTICAL COMPOSITIONS INCLUDING FLURBIPROFEN
KR960700061A (en) PHARMACEUTICAL COMPOSITION FOR TREATING NICOTINE DEPENDENCE
KR850700109A (en) Antidiuretic DDAVP and its preparation method
BR9916860A (en) Method of reducing blood cholesterol and / or other blood glycerides in a mammal individual, preparation in the form of a dosage unit, and, set to orally administer the same
KR920703041A (en) Ingredients and methods used to treat inflammatory or allergic diseases with pain
KR950007848A (en) Treatment of Anxiety with (S)-(-)-α-ethyl-2-oxo-1-pyrrolidineacetamide
RU95101385A (en) Products containing g-csf and tnf-binding protein
KR890007728A (en) Painkiller
JPS62298530A (en) Pharmaceutical composition for suppository
KR920702225A (en) Pharmaceutical composition
US3629412A (en) Topical anti-inflammatory agent
KR900007434A (en) Therapeutics with cystatin as active ingredients
KR930003913A (en) Methods and pharmaceutical compositions for enhancing the antitussive effect of dextromethorphan
KR890014110A (en) Medication
KR830008678A (en) Analgesic composition
DE60112584D1 (en) Process for the preparation of a liquid dosage unit and kit
ATE91890T1 (en) MANUFACTURE OF A DRUG AGAINST ARTHRITIS AND RHEUMATISM.
KR890015746A (en) How to treat AIDS cachexia with megestrol acetate

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid